Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Yajima

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
International Journal of Clinical Oncology|October 11, 2021
Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancersTatsuki Nanami, Isamu Hoshino, Fumiaki Shiratori, et al.
Molecular and Clinical Oncology|August 9, 2020
Prevalence of autoantibodies against Ras-like GTPases, RalA, in patients with gastric cancerTatsuki Nanami, Isamu Hoshino, Masaaki Ito, et al.
Annals of Gastroenterological Surgery|June 4, 2020
Prognostic impact of p53 and/or NY-ESO-1 autoantibody induction in patients with gastroenterological cancersIsamu Hoshino, Yoshihiro Nabeya, Nobuhiro Takiguchi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 3, 2021
Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassayHideaki Kato, Kei Miyakawa, Norihisa Ohtake, et al.
Cancer Medicine|December 23, 2019
High serum PD-L1 level is a poor prognostic biomarker in surgically treated esophageal cancerMasaaki Ito, Satoshi Yajima, Takashi Suzuki, et al.
Esophagus : Official Journal of the Japan Esophageal Society|July 1, 2018
Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinomaTakashi Suzuki, Satoshi Yajima, Nobuki Ishioka, et al.
Molecular and Clinical Oncology|July 19, 2021
Prevalence of serum galectin-1 autoantibodies in seven types of cancer: A potential biomarkerTatsuki Nanami, Isamu Hoshino, Fumiaki Shiratori, et al.
Vaccine|April 4, 2022
Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccinationHideaki Kato, Kei Miyakawa, Norihisa Ohtake, et al.
Journal of Thrombosis and Thrombolysis|July 18, 2012
Plasma accumulation of fondaparinux 2.5 mg in patients after total hip arthroplastyYohei Yukizawa, Yutaka Inaba, Shin-Ichiro Watanabe, et al.
International Journal of Oncology|October 4, 2007
Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancerSatoshi Yajima, Mie Ishii, Hisayuki Matsushita, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
International Journal of Clinical Oncology|October 11, 2021
Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancersTatsuki Nanami, Isamu Hoshino, Fumiaki Shiratori, et al.
Molecular and Clinical Oncology|August 9, 2020
Prevalence of autoantibodies against Ras-like GTPases, RalA, in patients with gastric cancerTatsuki Nanami, Isamu Hoshino, Masaaki Ito, et al.
Annals of Gastroenterological Surgery|June 4, 2020
Prognostic impact of p53 and/or NY-ESO-1 autoantibody induction in patients with gastroenterological cancersIsamu Hoshino, Yoshihiro Nabeya, Nobuhiro Takiguchi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 3, 2021
Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassayHideaki Kato, Kei Miyakawa, Norihisa Ohtake, et al.
Cancer Medicine|December 23, 2019
High serum PD-L1 level is a poor prognostic biomarker in surgically treated esophageal cancerMasaaki Ito, Satoshi Yajima, Takashi Suzuki, et al.
Esophagus : Official Journal of the Japan Esophageal Society|July 1, 2018
Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinomaTakashi Suzuki, Satoshi Yajima, Nobuki Ishioka, et al.
Molecular and Clinical Oncology|July 19, 2021
Prevalence of serum galectin-1 autoantibodies in seven types of cancer: A potential biomarkerTatsuki Nanami, Isamu Hoshino, Fumiaki Shiratori, et al.
Vaccine|April 4, 2022
Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccinationHideaki Kato, Kei Miyakawa, Norihisa Ohtake, et al.
Journal of Thrombosis and Thrombolysis|July 18, 2012
Plasma accumulation of fondaparinux 2.5 mg in patients after total hip arthroplastyYohei Yukizawa, Yutaka Inaba, Shin-Ichiro Watanabe, et al.
International Journal of Oncology|October 4, 2007
Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancerSatoshi Yajima, Mie Ishii, Hisayuki Matsushita, et al.
Pageof 8